| M.
Sawkat Anwer, Ph.D. (Professor; Tufts University School of Veterinary Medicine)
Kansas State, 1973. Hormonal regulation of hepatic solute transport and bile formation;
signal transduction; hepatoxicity. (Sackler faculty) Martin
Beinborn, M.D. (Assistant Professor of Medicine). Molecular pharmacology of
peptide hormones; cholecystokinin receptors; glucagon-like peptide receptors as
drug targets for the treatment of diabetes and obesity. (Sackler faculty)
Margery C. Beinfeld, Ph.D. (Professor)
Washington (St. Louis), 1973. Neuropeptide biosynthesis, processing, and release;
enzymology of posttranslational modifications of proteins.(Sackler faculty)
Faculty member not accepting students at this time.
John J. Bymes, Ph.D. (Lecturer, Department
of Psychiatry). Ohio State University, 1996; Neuropharmacology. Neurobiology of
schizophrenia, bipolar disorder, and drug addiction.
Daniel B. Carr, M.D. (Lecturer)
(Anesthesia) Pain research; meta-analysis of pain therapies.
John J. Castellot, Jr., Ph.D.
(Professor of Anatomy and Cell Biology) Harvard, 1978. Mechanisms
of action of heparan sulfates; cell culture models for therapeutic
intervention in restenosis; cellular and molecular mechanisms regulating
blood vessel formation. (Sackler faculty)
Domenic A. Ciraulo, M.D. (Lecturer)
(Psychiatry) Pharmacokinetics and clinical utility of antidepressents
in patients with alcoholism and depression; pharmacodynamics of
benzodiazepines in children of alcoholics; receptor and behavioral
effects of prenatal exposure to ethanol and benzodiazepines.
Michael H. Court, BVsc, Ph.D. (Associate
Professor) University of Queensland, 1983; Tufts University, 2000.
Pharmacogenetics of drug-metabolizing enzymes; structure-function
of UDP-glucuronosyltransferases; inter- and intra-species differences
in drug metabolism. (Sackler faculty)
Faculty member not accepting students at this time.
Charles L. Crespi, Ph.D. (Adjunct
Associate Professor) Novel methods for drug discovery support using
heterologously-expressed human drug metabolizing enzymes.
Jonathan M Davis, M.D. (Professor of Pediatrics) Tufts University, School of Medicine (Sackler faculty)
Jeanne M. Fahey, Ph.D. (Research
Assistant Professor) SUNY Binghamton, 1990. Pharmacology of the
GABAA and NMDA receptors; molecular mechanisms of tolerance and
withdrawal; drug sensitivity in the elderly; role of cytokines and
neurosteroids in neurodegenerative disorders.
Faculty member not accepting students at this time.
David J. Greenblatt, M.D.
(Professor and Chair) Harvard, 1970. Pharmacokinetics and pharmacodynamics;
clinical psychopharmacology; metabolism of psychoactive agents;
neuropharmacology of the GABA benzodiazepine receptor. (Sackler faculty)
Faculty member not accepting students at this time.
Jonathan D. Griswold, M.D. (Assistant
Professor of Anesthesia) Pre-operative sedation of the pediatric
patient; anesthetic care for the pre-term infant.
Ronald P. Hammer, Jr., Ph.D. (Professor
of Psychiatry and Neuroscience and Anatomy) UCLA, 1980. Psychostimulant
sensitization and withdrawal; hormonal regulation of opioid peptides
and receptors; pharmacology of chronic drug treatment. (Sackler faculty)
Faculty member not accepting students at this time.
Jerold S. Harmatz, B.A. (Assistant
Professor of Psychiatry) Statistical planning and analysis of drug
trials.
Patricia L. Hibberd, M.D., Ph.D. (Professor of Medicine, Pediatrics and Public Health
Faculty, Sackler Graduate Program in Pharmacology and Experimental Therapeutics.,
Director, Center for Global Health Research
Nutrition and Infection Unit.)
Kenneth I. Kaitin, Ph.D. (Director,
Tufts Center for the Study of Drug Development; Associate Research
Professor of Medicine; Assistant Professor of Pharmacology) University
of Rochester, 1982; Pharmaceutical development, regulation, and
public policy.
Roy L. Kisliuk, Ph.D. (Professor
of Biochemistry) Case Western Reserve, 1956. Folate enzymes, coenzymes,
and antimetabolites.(Sackler faculty)
Clifford M. Knapp, Ph.D. (Adjunct
Assistant Professor) Pharmacology of substance abuse; pharmacokinetics
and clinical utility of antidepressents in patients with alcoholism
and depression.
Alan S. Kopin, M.D. (Professor of Medicine) University of North Carolina at Chapel Hill, 1981.
Research efforts focus on understanding structure-function relationships, mechanisms of intracellular signal transduction and physiologic functions of G-protein coupled receptors (GPCRs) with particular interests in metabolic and neurologic disease. (Sackler faculty)
Bart E. Laurijssens, Ph.D.
(Adjunct Instructor) Tufts Univsity, 2000.
Laura Liscum, Ph.D.
James E. Marchand, Ph.D. (Assistant
Professor of Anesthesia) Plasticity in sensory processing.
Karina F. Meiri, Ph.D (Professor
of Anatomy and Cellular Biology)
Klaus A. Miczek, Ph.D. (Professor
of Psychology) Chicago, 1972. Behavioral pharmacology and neuropharmacology
of aggression. (Sackler faculty)
Lawrence G. Miller, M.D. (Adjunct
Associate Professor) Behavioral and neurochemical effects of acute
and chronic benzodiazepine administration; biotechnology venture
capital funds.
R. Scott Obach, Ph.D. (Adjunct
Assistant Professor) Application of enzyme kinetics to drug metabolism;
in vitro-in vivo correlations for prediction of human pharmacokinetics;
the mechanism of cytochrome P450.
Peter Ofner, Ph.D. (Associate Professor
of Urology) Hormonal carcinogenesis of the prostate linked to aging;
toxicant- and aging-induced oxidative stress in the prostate.
Nanette Orme-Johnson, Ph.D.
(Associate Professor of Biochemistry) Wisconsin, 1973. Molecular
mechanisms of peptide hormones; control of steroid hormone biosynthesis.
(Sackler faculty)
Emmanuel N. Pothos, Ph.D. (Associate
Professor). Mechanism of synaptic plasticity in monoamine neurotransmission.
Neuropharmacology of drug addiction, psychosis, feeding disorders
and Parkinson's disease. (Sackler faculty)
Faculty member not accepting students at this time.
Clemens G. Richert, Ph.D. (Associate
Professor of Bioorganic Chemistry) Munich, 1993; ETH Zurich, 1994.
Organic, bioorganic, and medicinal chemistry of nucleic acids and
porphyrins.
Joseph M. Scavone, Pharm. D.
(Adjunct Assistant Professor) Clinical pharmacology of drug therapy
in the aged patient.
Ullrich S. Schwertschlag, M.D.,
Ph.D. (Adjunct Associate Professor) Clinical studies in the
areas of inflammation and immunology; clinical pharmacology of protein
drugs and small molecules.
Richard I. Shader, M.D. (Professor)
NYU, 1960. Mechanism of action of antianxiety and antidepressant
drugs; clinical pharmacology and psychopharmacology; effects of
aging on drug responses. (Sackler faculty)
Faculty member not accepting students at this time.
Jurgen Schmider, M.D. ( )
Orian Shirihai, MD Ph.D (Adjunct Associate
Professor in Pharmacology and Experimental Therapeutics) Mitochondrial biology. Role of mitocondria in differentiation
of blood projenitors, Role of mitochondria in pancreatic beta cell
fuel sensing, Insulin secretion and Diabetes. Mitochondrial drug
toxicity.
Louis Shuster, Ph.D. (Professor)
Johns Hopkins, 1954. Biochemical mechanisms of narcotic addiction;
pharmacogenetics; drug metabolism; behavioral pharmacology. (Sackler
faculty)
Faculty member not accepting students at this time.
Paul R. Skolnik, M.D. (Adjunct
Associate Professor of Medicine; Chief, Section of Infectious Diseases,
Professor of Medicine, and Director, Center for HIV/AIDS Care and
Research (CHACR) at Boston University Medical Center) Pennsylvania,
1981. Factors affecting HIV replication, including chemokines, cytokines,
and cytomegalovirus; antiretroviral and immune-based therapies;
HIV and metabolism. (Sackler faculty)
Jeffrey B. Tatro, Ph.D. (Associate
Professor of Medicine) Michigan, 1985. Neuroendocrine and inflammatory
roles of CNS neuropeptides; pharmacology of melanocortin receptors.
(Sackler faculty)
Theoharis C. Theoharides, Ph.D.,
M.D. (Professor) Yale, 1978, 1983. Immunopharmacology; role
of mast cells in stress-induced inflammatory conditions and effects
of drugs on mast cell secretion; clinical pharmacology of autoimmune
diseases; regulation of release from secretory cells by phosphoproteins.
(Sackler faculty)
Faculty member not accepting students at this time
Barry A. Trimmer, Ph.D. (Associate
Professor of Biology) Cambridge, 1983. Cellular and molecular mechanisms
of behavior; integration of signals by cholinergic receptors; role
of the nitric oxide-cGMP system in a model insect CNS. (Sackler faculty)
Karthik Venkatakrishnan, Ph.D. (Adjunct Assistant Professor,
Associate Director, Clinical Pharmacology, Pfizer Inc., Groton,
CT) Tufts University 2000. Integration of Drug Metabolism and Clinical
Pharmacology in Drug Development; Clinical Pharmacokinetics and
Pharmacodynamics; Drug Interaction Risk Assessment; Assessment of
CNS Distribution and Receptor Occupancy.
|